Transdermal Therapeutics Revenue, Growth & Competitor Profile

Company Profile & Annual Report for Transdermal Therapeutics

Access the complete profile.

Transdermal Therapeutics Fast Facts

Revenue	$10 - $100 million    See Exact Annual Revenue
Employees	10 - 100Exact Company Size
Primary Industry	44611 Pharmacies & Drug Stores
Address	211 Summit Parkway Suite 126 Birmingham, AL 35209

Note: Revenues for privately held companies are statistical evaluations.


Transdermal Therapeutics's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Transdermal Therapeutics's annual revenues are $10 - $100 million (see exact revenue data)
• What industry is the company in?
  • Transdermal Therapeutics is classified as operating in the Pharmacies & Drug Stores industry, NAICS Code 44611.

Transdermal Therapeutics Annual Revenue and Growth Rate

Transdermal Therapeutics	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	$10 - $100 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Transdermal Therapeutics's revenues are gauged from an analysis of company filings.

Transdermal Therapeutics's Income Statement (based on Industry Averages)

Transdermal Therapeutics P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Transdermal Therapeutics is developing and marketing. Transdermal Therapeutics doesn't have any recent trademark applications, indicating Transdermal Therapeutics is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
TRANSDERMAL THERAPEUTICS Medical services, namely, pharmaceutical drug compounding for the purpose of pain management	06/27/2011

See all trademarks and details in the Full Report.

Market Share of Transdermal Therapeutics's Largest Competitors

A competitive analysis shows these companies are in the same general field as Transdermal Therapeutics, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
CVS HEALTH	Woonsocket, RI	100
CVS PHARMACY	Woonsocket, RI	39
WALGREEN	Deerfield, IL	35
RITE AID	Harrisburg, PA	4
TRULIEVE	Tallahassee, FL	1
TRULIEVE	Clearwater, FL	1
KPH HEALTHCARE SERVICES	Gouverneur, NY	1
PHARMERICA	Louisville, KY	1

Nearby Competitors

These companies are similar in business line and location to Transdermal Therapeutics. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
PROXSYSRX	Birmingham, AL	100
PHARMAPOINT	Birmingham, AL	73
MILLS PHARMACY	Birmingham, AL	46
WELLNESS PHARMACY	Birmingham, AL	35
IMEDEQUIP	Birmingham, AL	34
TRANSDERMAL THERAPEUTICS	Birmingham, AL	21

Future Competition: Transdermal Therapeutics's Fastest Growing Competitors

These companies are in the same general field as Transdermal Therapeutics and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)